All News

Undergoing cancer treatment is like pulling weeds — we hope we got the last of it and it does not return, but we can never be sure.

Certain levels of immune cells in the breast tissue were associated with better survival in triple-negative breast cancer, according to recent research.

Enhertu has been approved by the FDA for certain patients with unresectable or metastatic HER2-positive solid tumors.

Since January 2024, the Food and Drug Administration has approved several treatments and combinations for solid tumors.

When my doctor told me, "I want to talk to you about something," I suddenly felt worried — thankfully it was good news.

From WWE champion Roman Reigns sharing about his leukemia status to Arizona rep. Raúl Grijalva announcing diagnosis, here’s what’s going on in the oncology space this week.

The Food and Drug Administration approved Abecma for adults with relapsed or refractory multiple myeloma who have received two or more previous lines of therapy.

When I was my husband's caregiver, I tried to make things comfortable, but I'm not sure if the drugs and bedpans could ever make it right.

Treatment with immune checkpoint inhibitors has improved survival outcomes for patients with metastatic bladder cancer, compared with chemotherapy.

An expert explains how gene-expression profile testing can inform treatment decisions for patients with squamous cell carcinoma.

Before cancer, I started to lose myself, but cancer taught me that loving myself isn't selfish.

Camille Wahl has had osteosarcoma since she was 10, and she found a tireless advocate in her mother.

My plastic surgeon helped me accept my new face after basal cell carcinoma left a hole in my face.

There is no difference in treatment for non-secretory multiple myeloma and multiple myeloma, an expert told CURE®.

A vaccine developer discusses a cancer vaccine that has been shown to potentially boost long-term overall postsurgical survival.

When I wore my street clothes in the hospital instead of a gown, I felt more like a person than a patient with cancer.

Childbirth rates have been reduced by 22% in women with MPNs, compared with women without MPNs, researchers found.

Of everything I've ever done, I wonder how my multiple myeloma came to be.

Recent research has shown encouraging results for older patients with classical Hodgkin lymphoma treated with Adcetris plus chemotherapy or Opdivo.

The Food and Drug Administration granted UTD1 an orphan drug designation to treat brain metastases in patients with breast cancer.

Questions about cancer can often be confusing and frustrating.

Melanoma survivors may have an increased risk of recurrence, which may heighten fear and worry, but “it’s OK and normal to be worried,” a doctor said.

The firsts I experienced after receiving a diagnosis of triple-negative breast cancer opened my eyes to the beauty of life.

Certain patient characteristics may put them at an increased risk for chemotherapy-related kidney injury, recent research found.

The Food and Drug Administration approved multiple new therapies for blood cancer over the last few months.

Recurrence is common enough that all of us need to act on potential symptoms.

Treatment for HER2-positive breast cancer depends on staging and can be intensified or de-escalated depending on disease characteristics, explained Dr. Debu Tripathy.

Cancer comes with an awful storm, but the prisms of light can make it a little less worse.

The threat of breast cancer looms over me, even the pain is a threat.

When I have scanxiety, I try to reduce my anxiety by taking warm baths and writing.